Ignite Creation Date:
2024-05-06 @ 1:02 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03913143
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-03-17
First Post:
2019-02-21
Brief Title:
A Study to Evaluate Efficacy Safety Tolerability and Exposure After a Repeat-dose of Sepofarsen QR-110 in LCA10 ILLUMINATE
Sponsor:
ProQR Therapeutics
Organization:
ProQR Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-21
First Submit QC Date:
April 11 2019
Study First Post Date:
2019-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-02
Last Update Post Date:
2022-03-17
Last Update Post Date Type:
ACTUAL